• Western blot analysis of lysates from A431 cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-SRSF12 antibody (105-155 aa) (STJ195594)

SKU:
STJ195594

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Serine/arginine-rich splicing factor 12 (105-155 aa) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: SRSF12
Gene ID: 135295
Uniprot ID: SRS12_HUMAN
Immunogen Region: 105-155 aa
Specificity: This antibody detects endogenous levels of SRS12 at Human/Mouse
Immunogen: Synthesized peptide derived from the human SRS12 at the amino acid range 105-155
Function Splicing factor that seems to antagonize SR proteins in pre-mRNA splicing regulation.
Protein Name Serine/Arginine-Rich Splicing Factor 12
35 Kda Sr Repressor Protein
Srrp35
Splicing Factor - Arginine/Serine-Rich 13b
Splicing Factor - Arginine/Serine-Rich 19
Database Links Reactome: R-HSA-72163
Reactome: R-HSA-72203
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Serine/Arginine-Rich Splicing Factor 12 antibody
Anti-35 Kda Sr Repressor Protein antibody
Anti-Srrp35 antibody
Anti-Splicing Factor - Arginine/Serine-Rich 13b antibody
Anti-Splicing Factor - Arginine/Serine-Rich 19 antibody
Anti-SRSF12 antibody
Anti-SFRS13B antibody
Anti-SFRS19 antibody
Anti-SRRP35 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance